Dsf/cu induces antitumor effect against diffuse large b-cell lymphoma through suppressing nf-κb/bcl6 pathways

HIGHLIGHTS

• who: Yunying Zhu from the (UNIVERSITY) have published the Article: DSF/Cu induces antitumor effect against diffuse large B-cell lymphoma through suppressing NF-u03baB/BCL6 pathways, in the Journal: (JOURNAL)
• what: This study aimed to explore the role and potential antitumor mechanism of DSF/Cu on DLBCL.
• how: These results indicated that DSF may be a new BCL6 inhibitor with therapeutic potential for DLBCL. The data was analyzed with 10.6.2 FlowJo software. These results indicated that DSF/Cu induced u0394u03a8m loss in DLBCL cells. The data indicated that DSF or . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.